Nestle : Friendly bid for Aimmune Therapeutics to create a global leader in the treatment of food allergies
>Strategic focus maintained - Buy rating maintained. With the announcement of the takeover bid for Aimmune Therapeutics, Nestlé is once again demonstrating that it is maintaining its strategic course of transforming its portfolio, despite the challenging context. The price offered is inevitably high for a target that does not generate any sales. But the potential is significant and above all Aimmune brings the third pillar of Medical Nutrition: the treatment of food a...Nestle is a holding company which is based in Switzerland. Through its subsidiaries and allied companies, Co. is engaged in the food processing industry. Co.'s product portfolio has seven categories, Powder and Liquid Beverages, Nutritional and Health Science, Milk products and ice cream, Prepared dishes and cooking aids, PetCare, Confectionery and Water.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.